
Virginia Moves Closer to Legal Cannabis Sales as Bills Advance
House and Senate push companion legislation toward final votes, setting up showdown with Governor Youngkin
Virginia lawmakers took decisive steps this week to establish a regulated adult-use cannabis market, with both chambers advancing companion bills that could finally bring retail sales to the Commonwealth.
The House of Delegates passed a Senate-approved cannabis sales bill on second reading Tuesday, moving it one vote away from heading to Governor Glenn Youngkin's desk. Meanwhile, a Senate committee advanced the House version of the legislation, keeping both tracks alive as lawmakers work to reconcile differences before the session ends.
Virginia legalized personal possession and home cultivation of marijuana in 2021, but left the commercial market in limbo—creating what critics call a "grow but can't buy" situation that's lasted nearly four years. The current bills aim to fix that by establishing licensed dispensaries, cultivation facilities, and testing labs.
The Political Calculus
The legislation faces an uncertain future with Governor Youngkin, who has previously expressed opposition to expanding Virginia's cannabis program. His administration has signaled concerns about public health impacts and youth access, though he hasn't committed to a veto.
But the bills are moving through both chambers with bipartisan support, suggesting lawmakers see political momentum—and potential tax revenue—as worth the fight. Virginia's medical cannabis program already operates 70+ dispensaries statewide, providing infrastructure that could transition to adult-use sales.
The companion bills include provisions for social equity applicants, expungement of prior marijuana convictions, and local control allowing counties to opt out of hosting dispensaries. Tax revenue would be split between education, public health programs, and communities disproportionately impacted by prohibition.
What the Industry Sees
Virginia's existing medical cannabis operators have been watching closely, positioned to capture early market share if retail sales launch. But the bills also create pathways for new businesses, particularly those owned by people from communities harmed by the war on drugs.
"The infrastructure is already there," said one Richmond-based cannabis attorney who requested anonymity to speak freely about pending legislation. "The question is whether Youngkin sees the economic opportunity or digs in on opposition."
Neighboring states offer a preview of what's at stake. Maryland launched adult-use sales in 2023 and generated over $100 million in tax revenue within the first six months. North Carolina is considering its own legalization push this session.
Timeline and Next Steps
The House bill needs one more floor vote before heading to the Senate for consideration. The Senate version, already passed by that chamber, awaits a final House vote after Tuesday's second reading approval.
If both bills reach Youngkin's desk, he'll have 30 days to sign, veto, or let them become law without his signature. A veto would require a two-thirds majority in both chambers to override—a heavy lift even with bipartisan support.
The General Assembly's session ends in late February, creating a tight window for final passage and any potential override attempts. Industry observers expect a decision by mid-March at the latest.
Virginia would become the 25th state to legalize recreational cannabis sales if the bills become law, joining a growing regional cluster that includes Maryland, New Jersey, and Delaware.
This article is based on original reporting by www.marijuanamoment.net.
Original Source
This article is based on reporting from Marijuana Moment.
Read the original articleOriginal title: "Virginia House And Senate Lawmakers Advance Marijuana Sales Legalization Bills Toward Governor’s Desk"
Related Topics
Related Stories
LegislationConnecticut Expands Psychedelics Pilot as FDA Decision Looms
Connecticut's Joint Committee on Public Health advanced legislation expanding the state's psychedelic therapy pilot program to include first responders, as lawmakers prepare for potential FDA approval of MDMA and psilocybin treatments.
LegislationRescheduling Won't Fix Cannabis Industry Without Insurance Access
Cannabis industry experts argue Trump's rescheduling order won't stabilize the market without insurance reimbursement access, which matters more than tax relief for long-term viability.
LegislationLaw Enforcement Coalition Pushes Congress to Uphold Hemp THC Ban
Law enforcement groups are urging Congress to let a federal ban on hemp-derived THC products take effect, opposing industry efforts to delay recriminalization of delta-8 and similar compounds that generate billions in annual sales.
More from Alex Morgan
View all articles
Bob Weir's Nuanced Cannabis Stance Defied 'Drug Band' Stereotypes

Rescheduling Won't Fix Cannabis Industry Without Insurance Access

Chicago's Cannabis Run Club Grows From 'Highdea' to Weekly Tradition

